Mapping Low-Dose Computed Tomography Lung Cancer Screening in Canada: A Scoping Review of Implementation, Eligibility, Access, Outcomes, Barriers, Facilitators, and Equity
Background. Lung cancer is the leading cause of cancer-related death in Canada, with a five-year survival of approximately 14% driven by late-stage diagnosis (Canadian Agency for Drugs and Technologies in Health, 2015). Low-dose computed tomography (LDCT) screening reduces lung cancer mortality by 20-24% in high-risk p...